Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wing C Chan

Showing results (191-200 of 295) with videos related to

Pageof 30
Sort By:
Blood|September 21, 2007
Mutations in the DNA-binding codons of TP53, which are associated with decreased expression of TRAILreceptor-2, predict for poor survival in diffuse large B-cell lymphomaKen H Young, Dennis D Weisenburger, Bhavana J Dave, et al.
Genes, Chromosomes & Cancer|September 8, 2007
Frequent occurrence of deletions in primary mediastinal B-cell lymphomaLindsey R Kimm, Ronald J deLeeuw, Kerry J Savage, et al.
Blood|December 8, 2009
Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphomaJaveed Iqbal, Dennis D Weisenburger, Timothy C Greiner, et al.
Leukemia & Lymphoma|April 2, 2015
Isolated MYC cytogenetic abnormalities in diffuse large B-cell lymphoma do not predict an adverse clinical outcomeGabriel C Caponetti, Bhavana J Dave, Anamarija M Perry, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 22, 2025
CAMKIIδ Reinforces Lipid Metabolism and Promotes the Development of B Cell LymphomaJiawei Zhang, Senlin Xu, Hui Fang, et al.
Blood|July 17, 2008
The presence of TP53 mutation at diagnosis of follicular lymphoma identifies a high-risk group of patients with shortened time to disease progression and poorer overall survivalDerville O'Shea, Ciarán O'Riain, Claire Taylor, et al.
Leukemia|December 9, 2025
Key regulatory roles of PRDM1 in human NK-cell differentiation and activationXuxiang Liu, Yunfei Shi, Jibin Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 8, 2019
Inhibition of MDR1 Overcomes Resistance to Brentuximab Vedotin in Hodgkin LymphomaRobert Chen, Alex F Herrera, Jessie Hou, et al.
Blood Advances|November 15, 2023
Pharmacological profiling of a berbamine derivative for lymphoma treatmentSenlin Xu, Shunquan Wu, Mingfeng Zhang, et al.
British Journal of Haematology|February 11, 2014
MYC and BCL2 protein expression predicts survival in patients with diffuse large B-cell lymphoma treated with rituximabAnamarija M Perry, Yuridia Alvarado-Bernal, Javier A Laurini, et al.
Pageof 30

Showing results (191-200 of 295) with videos related to

Sort By:
Pageof 30
Blood|September 21, 2007
Mutations in the DNA-binding codons of TP53, which are associated with decreased expression of TRAILreceptor-2, predict for poor survival in diffuse large B-cell lymphomaKen H Young, Dennis D Weisenburger, Bhavana J Dave, et al.
Genes, Chromosomes & Cancer|September 8, 2007
Frequent occurrence of deletions in primary mediastinal B-cell lymphomaLindsey R Kimm, Ronald J deLeeuw, Kerry J Savage, et al.
Blood|December 8, 2009
Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphomaJaveed Iqbal, Dennis D Weisenburger, Timothy C Greiner, et al.
Leukemia & Lymphoma|April 2, 2015
Isolated MYC cytogenetic abnormalities in diffuse large B-cell lymphoma do not predict an adverse clinical outcomeGabriel C Caponetti, Bhavana J Dave, Anamarija M Perry, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 22, 2025
CAMKIIδ Reinforces Lipid Metabolism and Promotes the Development of B Cell LymphomaJiawei Zhang, Senlin Xu, Hui Fang, et al.
Blood|July 17, 2008
The presence of TP53 mutation at diagnosis of follicular lymphoma identifies a high-risk group of patients with shortened time to disease progression and poorer overall survivalDerville O'Shea, Ciarán O'Riain, Claire Taylor, et al.
Leukemia|December 9, 2025
Key regulatory roles of PRDM1 in human NK-cell differentiation and activationXuxiang Liu, Yunfei Shi, Jibin Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 8, 2019
Inhibition of MDR1 Overcomes Resistance to Brentuximab Vedotin in Hodgkin LymphomaRobert Chen, Alex F Herrera, Jessie Hou, et al.
Blood Advances|November 15, 2023
Pharmacological profiling of a berbamine derivative for lymphoma treatmentSenlin Xu, Shunquan Wu, Mingfeng Zhang, et al.
British Journal of Haematology|February 11, 2014
MYC and BCL2 protein expression predicts survival in patients with diffuse large B-cell lymphoma treated with rituximabAnamarija M Perry, Yuridia Alvarado-Bernal, Javier A Laurini, et al.
Pageof 30